Skip to main content
FinSpry Logo
FinSpry
B
BMY
(NYSE)
Bristol-Myers Squibb Company
$59.60-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Bristol-Myers Squibb Company (BMY) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Bristol-Myers Squibb Company stock.

Analyst Consensus Rating

Investment consensus from 27 professional research analysts

Consensus Rating

Buy
Based on 27 unique analysts
(35 total ratings in last 90 days)
Very High Confidence15.0:1 Buy/Sell

Average Price Target

$63.83
↑ 7.10% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest BMY Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Rob Williams
The Motley Fool
BuyInitiates Coverage
-
Mike Zaccardi, CFA, CMT
Investing.com
BuyInitiates Coverage
-
Rajesh Kumar
HSBC
HoldMaintains
$53.00 → $60.00
Trung Huynh
RBC Capital
HoldInitiates
$60.00
Trung Huynh
RBC Capital
HoldInitiates
$60.00
David Amsellem
Piper Sandler
BuyMaintains
$66.00 → $75.00
Emily Field
Barclays
BuyInitiates
$75.00
Emily Field
Barclays
BuyInitiates
$75.00
Google Drug Manufacturers - General
TipRanks - Google
BuyReiterates
$65.00 → $69.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$63.00 → $70.00
Anthropic Drug Manufacturers - General
TipRanks - Anthropic
HoldUpgrades
$61.00 → $66.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
BuyReiterates
$62.00 → $68.00
xAi Drug Manufacturers - General
TipRanks - xAI
HoldUpgrades
$61.00 → $66.00
OpenAI Drug Manufacturers - General
TipRanks - OpenAI
BuyReiterates
$62.00 → $67.00
Louise Chen
Scotiabank
HoldMaintains
$60.00
Seamus Fernandez
Guggenheim
Strong BuyMaintains
$62.00 → $72.00
Jason Gerberry
BofA Securities
BuyReiterates
$68.00
Geoff Meacham
Citi
HoldMaintains
$60.00 → $64.00
Mohit Bansal
Wells Fargo
HoldMaintains
$55.00 → $60.00
Terence Flynn
Morgan Stanley
SellMaintains
$37.00 → $40.00
Srikripa Devarakonda
Truist
BuyReiterates
$65.00
Evan Seigerman
BMO Capital
HoldMaintains
$55.00
Asad Haider
Goldman Sachs
HoldMaintains
$57.00
David Amsellem
Piper Sandler
BuyMaintains
$62.00 → $66.00
Chris Schott
JP Morgan
BuyMaintains
$65.00
Andrew Baum
Citi
HoldMaintains
$53.00 → $60.00
David Risinger
Leerink Partners
BuyMaintains
$54.00 → $60.00
Louise Chen
Scotiabank
HoldMaintains
$53.00 → $60.00
Evan Seigerman
BMO Capital
HoldMaintains
$47.00
Jasper Hellweg
Argus Research
HoldMaintains
-
Michael Yee
UBS
Strong BuyUpgrades
$46.00 → $65.00
Andrew Baum
Citi
HoldMaintains
$45.00 → $53.00
David Amsellem
Piper Sandler
BuyReiterates
$62.00
Trung Huynh
UBS
BuyDowngrades
$46.00 → $65.00
Geoff Meacham
Citi
HoldMaintains
$45.00 → $53.00

Frequently Asked Questions

What is the analyst consensus rating for BMY?

The analyst consensus rating for BMY is "Buy" based on 27 analyst recommendations.

What is the average price target for BMY?

The average 12-month price target for BMY is $63.83, representing an upside of 7.1% from the current price of $59.60.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.